Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of xylometazoline versus cocaine for prevention of epistaxis during nasal intubation
2021-000691-11Phase 3Completed
- Sponsor
- Rigshospitalet
- Start
- May 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in epistaxis comparing Xylometazoline arm with Cocaine arm (2 arms). Primary endpoint: Epistaxis severity score immediately after nasal intubation. Started May 2021; status: completed.
02
Drugs
xylometazolinecocaine
03
Conditions
epistaxis
Beyond the preview
Go deeper on 2021-000691-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000691-11.